# Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder

> **NCT05562973** · PHASE1 · WITHDRAWN · sponsor: **Johns Hopkins University**

## Conditions studied

- Post-Traumatic Stress Disorder

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT05562973
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The principal investigator will be at a new institution.
- **Last updated:** 2024-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05562973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05562973, "Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05562973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*